Cannabis Legalization and Cannabis Use Disorder by Sex in Veterans Health Administration Patients, 2005–2019.
Saved in:
| Title: | Cannabis Legalization and Cannabis Use Disorder by Sex in Veterans Health Administration Patients, 2005–2019. |
|---|---|
| Authors: | Wisell, Caroline G. (AUTHOR), Hasin, Deborah S. (AUTHOR), Wall, Melanie M. (AUTHOR), Alschuler, Daniel (AUTHOR), Malte, Carol (AUTHOR), McDowell, Yoanna (AUTHOR), Olfson, Mark (AUTHOR), Keyes, Katherine M. (AUTHOR), Cerdá, Magdalena (AUTHOR), Maynard, Charles C. (AUTHOR), Keyhani, Salomeh (AUTHOR), Martins, Silvia S. (AUTHOR), Mannes, Zachary L. (AUTHOR), Livne, Ofir (AUTHOR), Fink, David S. (AUTHOR), Bujno, Julia M. (AUTHOR), Stohl, Malki (AUTHOR), Saxon, Andrew J. (AUTHOR), Simpson, Tracy L. (AUTHOR) |
| Source: | Substance Use & Misuse. 2026, Vol. 61 Issue 2, p296-306. 11p. |
| Subjects: | Substance abuse risk factors, Drug abuse laws, Substance abuse diagnosis, Substance abuse, Cross-sectional method, Repeated measures design, Medical marijuana, Risk assessment, Medical care of veterans, Research funding, Sex distribution, United States. Dept. of Veterans Affairs, Age distribution, Descriptive statistics, Psychology of veterans, Drug abuse, Cannabis (Genus), Drug laws, Data analysis software, Confidence intervals, Regression analysis |
| Geographic Terms: | United States |
| Abstract: | Background: Understanding sex differences in the effects of cannabis legalization and increasing risk for cannabis use disorder (CUD) is important. We hypothesized that from 2005 to 2019, increases in CUD prevalence due to state medical or recreational cannabis laws (MCL; RCL) would differ among male and female veterans treated at the U.S. Veterans Health Administration (VHA), with greater increases among females. Methods: Data obtained through the VHA Corporate Data Warehouse included veterans 18–75 years with ≥1 VHA primary care, emergency department, or mental health visit in a given year, 2005–2019. Staggered-adoption difference-in-difference analyses were used to estimate the role of MCL and RCL on trends in CUD diagnostic prevalence, fitting a linear binomial regression model with fixed effects for state and categorical year, time-varying cannabis law status, state-level sociodemographic covariates, patient-level age group (18–35, 36–64, 65–75 years), race and ethnicity. Results: CUD prevalences increased in both sexes. CUD increased more in states enacting MCL and RCL than in states that did not enact CL. However, no CUD prevalence increases attributable to the change from no-CL to MCL-only or MCL to RCL differed significantly by sex, with one exception (greater in males aged 35–64). Conclusions: Increases in CUD prevalence following MCL or RCL enactment were greater than in states with no-CL, but generally did not show differences by sex. The increases in CUD prevalence occurring for males and females throughout the study years indicate the need for cannabis use screening by medical providers and the importance of offering evidence-based treatments for CUD. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: Understanding sex differences in the effects of cannabis legalization and increasing risk for cannabis use disorder (CUD) is important. We hypothesized that from 2005 to 2019, increases in CUD prevalence due to state medical or recreational cannabis laws (MCL; RCL) would differ among male and female veterans treated at the U.S. Veterans Health Administration (VHA), with greater increases among females. Methods: Data obtained through the VHA Corporate Data Warehouse included veterans 18–75 years with ≥1 VHA primary care, emergency department, or mental health visit in a given year, 2005–2019. Staggered-adoption difference-in-difference analyses were used to estimate the role of MCL and RCL on trends in CUD diagnostic prevalence, fitting a linear binomial regression model with fixed effects for state and categorical year, time-varying cannabis law status, state-level sociodemographic covariates, patient-level age group (18–35, 36–64, 65–75 years), race and ethnicity. Results: CUD prevalences increased in both sexes. CUD increased more in states enacting MCL and RCL than in states that did not enact CL. However, no CUD prevalence increases attributable to the change from no-CL to MCL-only or MCL to RCL differed significantly by sex, with one exception (greater in males aged 35–64). Conclusions: Increases in CUD prevalence following MCL or RCL enactment were greater than in states with no-CL, but generally did not show differences by sex. The increases in CUD prevalence occurring for males and females throughout the study years indicate the need for cannabis use screening by medical providers and the importance of offering evidence-based treatments for CUD. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10826084 |
| DOI: | 10.1080/10826084.2025.2554866 |
